Permeability and concentration of levofloxacin in epithelial lining fluid in patients with lower respiratory tract infections.

about

In vitro activity of levofloxacin against lower respiratory tract pathogens.Levofloxacin inhibits rhinovirus infection in primary cultures of human tracheal epithelial cells.Penetration of anti-infective agents into pulmonary epithelial lining fluid: focus on antibacterial agents.

P2860

Q35884515-8B846804-9C2A-42D9-B290-E23DF03FE8EA Q36171734-6990CF63-60EB-4344-88AE-5769CC66F1A3 Q37927017-44EEC54A-D8F6-4B1B-AF08-7E6CBEFF1D6C

P2860

Permeability and concentration of levofloxacin in epithelial lining fluid in patients with lower respiratory tract infections.

Item

http://www.wikidata.org/entity/Q43207762

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Permeability and concentration ...... respiratory tract infections.

@en

Permeability and concentration ...... respiratory tract infections.

@nl

type

Item

label

Permeability and concentration ...... respiratory tract infections.

@en

Permeability and concentration ...... respiratory tract infections.

@nl

prefLabel

Permeability and concentration ...... respiratory tract infections.

@en

Permeability and concentration ...... respiratory tract infections.

@nl

P1476

Permeability and concentration ...... respiratory tract infections.

@en

P2093

Guo-Ying Cao

http://www.w3.org/2001/XMLSchema#string

Ji-Cheng Yu

http://www.w3.org/2001/XMLSchema#string

Jing Zhang

http://www.w3.org/2001/XMLSchema#string

Xiao-Jie Wu

http://www.w3.org/2001/XMLSchema#string

Xin Xie

http://www.w3.org/2001/XMLSchema#string

Xin Zhou

http://www.w3.org/2001/XMLSchema#string

Yao-Guo Shi

http://www.w3.org/2001/XMLSchema#string

Ying-Yuan Zhang

http://www.w3.org/2001/XMLSchema#string

Yu-Qing Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia

Pharmacodynamics and pharmacokinetics of levofloxacin.

Activity of gemifloxacin and other new quinolones against Chlamydia pneumoniae: a review.

Evidence to support the rationale that bacterial eradication in respiratory tract infection is an important aim of antimicrobial therapy.

In vivo measurement of levofloxacin penetration into lung tissue after cardiac surgery.

Animal model pharmacokinetics and pharmacodynamics: a critical review.

In vitro susceptibilities to and bactericidal activities of garenoxacin (BMS-284756) and other antimicrobial agents against human mycoplasmas and ureaplasmas

Levofloxacin: an updated review of its use in the treatment of bacterial infections.

Steady-state plasma and bronchopulmonary concentrations of intravenous levofloxacin and azithromycin in healthy adults.

Susceptibilities of genital mycoplasmas to the newer quinolones as determined by the agar dilution method.

P304

922-928

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0091270009355160

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2009-12-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20035039

http://www.w3.org/2001/XMLSchema#string

Permeability and concentration of levofloxacin in epithelial lining fluid in patients with lower respiratory tract infections.

about

P2860

P2860

Permeability and concentration of levofloxacin in epithelial lining fluid in patients with lower respiratory tract infections.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698